BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer-Reference-Cited by-同舟云学术

BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer

Published:2019-08-28 Issue:1 Volume:39 Page:17-29
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Zhu Sen,Zhao Dongyu,Li Chao,Li Qiaqia,Jiang Weihua,Liu Qipeng,Wang Rui,Fazli Ladan,Li Yinan,Zhang Lili,Yi Yang,Meng Qingshu,Wang Wanyi,Wang Guangyu,Zhang Min,Zu Xiongbing,Zhao Wei,Deng Tuo,Yu Jindan,Dong Xuesen^ORCID,Chen Kaifu^ORCID,Cao Qi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-019-0966-4.pdf

Reference32 articles.

1. Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ, et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest. 2009;119:3626–36.

2. Ren H, Du P, Ge Z, Jin Y, Ding D, Liu X, et al. TWIST1 and BMI1 in cancer metastasis and chemoresistance. J Cancer. 2016;7:1074–80.

3. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest. 2005;115:1503–21.

4. van Leenders GJ, Dukers D, Hessels D, van den Kieboom SW, Hulsbergen CA, Witjes JA, et al. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features. Eur Urol. 2007;52:455–63.

5. Siddique HR, Saleem M. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences. Stem Cells. 2012;30:372–8.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BMI ‐1 promotes breast cancer proliferation and metastasis through different mechanisms in different subtypes;Cancer Science;2022-11-10

2. Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A;Discover Oncology;2022-10-01

3. Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer;International Journal of Molecular Sciences;2022-08-24

4. Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives;Pathology - Research and Practice;2022-08

5. Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A;2022-06-06